Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-005491
Filing Date
2025-01-22
Accepted
2025-01-22 16:15:12
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3326
  Complete submission text file 0001213900-25-005491.txt   4979
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Issuer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ONCONETIX, INC. 201 E. FIFTH STREET, SUITE 1900 CINCINNATI OH 45202
Business Address
Bruhlmann Christian (Reporting) CIK: 0002006197 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41294 | Film No.: 25546142